Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilma H M Hoevenaar

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
British Journal of Cancer|December 2, 2020
Emerging immunotherapies for metastasisSarah C Edwards, Wilma H M Hoevenaar, Seth B Coffelt
The Journal of Experimental Medicine|December 8, 2022
PD-1 and TIM-3 differentially regulate subsets of mouse IL-17A-producing γδ T cellsSarah C Edwards, Ann Hedley, Wilma H M Hoevenaar, et al.
EMBO Molecular Medicine|November 18, 2024
Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunityAlastair Copland, Gillian M Mackie, Lisa Scarfe, et al.
Nature Communications|March 22, 2020
Degree and site of chromosomal instability define its oncogenic potentialWilma H M Hoevenaar, Aniek Janssen, Ajit I Quirindongo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2026
Non-cell-autonomous mechanisms of tumor initiation and relapse by chromosomal instabilitySimona J A Lafirenze, Bastiaan van Gerwen, Ajit I Quirindongo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
British Journal of Cancer|December 2, 2020
Emerging immunotherapies for metastasisSarah C Edwards, Wilma H M Hoevenaar, Seth B Coffelt
The Journal of Experimental Medicine|December 8, 2022
PD-1 and TIM-3 differentially regulate subsets of mouse IL-17A-producing γδ T cellsSarah C Edwards, Ann Hedley, Wilma H M Hoevenaar, et al.
EMBO Molecular Medicine|November 18, 2024
Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunityAlastair Copland, Gillian M Mackie, Lisa Scarfe, et al.
Nature Communications|March 22, 2020
Degree and site of chromosomal instability define its oncogenic potentialWilma H M Hoevenaar, Aniek Janssen, Ajit I Quirindongo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2026
Non-cell-autonomous mechanisms of tumor initiation and relapse by chromosomal instabilitySimona J A Lafirenze, Bastiaan van Gerwen, Ajit I Quirindongo, et al.
Pageof 1